{"text": "Retinoid X receptor ( RXR ) agonist - induced activation of dominant - negative RXR - <extra_id_0> retinoic acid receptor alpha403 <extra_id_2> Protein <extra_id_1> heterodimers is developmentally regulated during myeloid differentiation .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The multiple biologic activities of retinoic acid ( RA ) are mediated through RAR and retinoid X receptor ( RXR ) nuclear receptors that interact with specific DNA target sequences as heterodimers ( RXR-RAR ) or homodimers ( RXR-RXR ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "RA receptor activation appears critical to regulating important aspects of hematopoiesis , since transducing a COOH-terminally truncated <extra_id_0> RARalpha <extra_id_2> Protein <extra_id_1> exhibiting dominant - negative activity ( <extra_id_0> RARalpha403 <extra_id_2> Protein <extra_id_1> ) into normal mouse bone marrow generates hematopoietic growth factor - dependent cell lines frozen at the multipotent progenitor ( EML ) or committed promyelocyte ( MPRO ) stages .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Nevertheless , relatively high , pharmacological concentrations of RA ( 1 to 10 & mgr ; M ) overcome these differentiation blocks and induce terminal granulocytic differentiation of the MPRO promyelocytes while potentiating <extra_id_0> interleukin-3 <extra_id_2> Protein <extra_id_1> ( <extra_id_0> IL-3 <extra_id_2> Protein <extra_id_1> ) - induced commitment of EML cells to the granulocyte / monocyte lineage .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "In the present study , we utilized RXR - and RAR - specific agonists and antagonists to determine how RA overcomes the dominant - negative activity of the truncated <extra_id_0> RARalpha <extra_id_2> Protein <extra_id_1> in these different myeloid developmental stages .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Unexpectedly , we observed that an RXR - specific , rather than an RAR - specific , agonist induces terminal granulocytic differentiation of MPRO promyelocytes , and this differentiation is associated with activation of DNA response elements corresponding to RAR-RXR heterodimers rather than RXR-RXR homodimers .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "This RXR agonist activity is blocked by RAR - specific antagonists , suggesting extensive cross-talk between the partners of the RXR - <extra_id_0> RARalpha403 <extra_id_2> Protein <extra_id_1> heterodimer .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "In contrast , in the more immature , multipotent EML cells we observed that this RXR - specific agonist is inactive either in potentiating <extra_id_0> IL-3 <extra_id_2> Protein <extra_id_1> - mediated commitment of EML cells to the granulocyte lineage or in transactivating RAR-RXR response elements .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "RA - triggered GALdbd - <extra_id_0> RARalpha <extra_id_2> Protein <extra_id_1> hybrid activity in these cells indicates that the multipotent EML cells harbor substantial nuclear hormone receptor coactivator activity .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "However , the histone deacetylase ( HDAC ) inhibitor trichostatin A readily activates an RXR-RAR reporter construct in the multipotent EML cells but not in the committed MPRO promyelocytes , indicating that differences in HDAC - containing repressor complexes in these two closely related but distinct hematopoietic lineages might account for the differential activation of the RXR - <extra_id_0> RARalpha403 <extra_id_2> Protein <extra_id_1> heterodimers that we observed at these different stages of myeloid development .", "event": "<extra_id_0> <extra_id_1>"}
